Sunshine Biopharma's three largest insider shareholders as of June 06, 2026 are Camille Sebaaly (Cfo/Secretary, 174.47K shares), Steve N. Slilaty (Chief Executive Officer, 130.00K shares), David Natan (Director, 100.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| David Natan | - | 100,000 | 0 | 14 Apr, 2026 |
| Steve N. Slilaty | Chief Executive Officer | 130,000 | 0 | 05 Mar, 2024 |
| Camille Sebaaly | Cfo/Secretary | 174,465 | 0 | 01 Dec, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 14 Apr, 2026 | David Natan | Common Stock | A | 100,000 | $0.00 | 100,000 | D | A |
| 04 Mar, 2024 | Steve N. Slilaty | Series B Preferred Stock | A | 100,000 | $0.10 | 130,000 | D | P |
| 08 Feb, 2024 | Steve N. Slilaty | Series B Preferred Stock | A | 20,000 | $0.10 | 30,000 | D | P |
| 30 Nov, 2022 | Camille Sebaaly | Common Stock | A | 30,000 | $0.76 | 174,465 | D | P |
| 03 Jun, 2022 | Camille Sebaaly | Common Stock | A | 25,000 | $1.22 | 144,465 | D | P |
| 18 Feb, 2022 | Steve N. Slilaty | Series B Preferred Stock | D | 990,000 | $0.10 | 10,000 | D | D |
| 06 Jan, 2021 | Abderrazzak Merzouki | Common Stock | A | 20,000,000 | $0.00 | 23,342,500 | D | A |
| 06 Jan, 2021 | Camille Sebaaly | Common Stock | A | 20,000,000 | $0.00 | 23,893,086 | D | A |
| 06 Jan, 2021 | Steve N. Slilaty | Common Stock | A | 20,000,000 | $0.00 | 23,343,461 | D | A |
| 17 Jun, 2020 | Steve N. Slilaty | Series B Preferred Stock | A | 500,000 | $0.10 | 1,000,000 | D | A |
| 02 Sep, 2019 | Camille Sebaaly | Common Stock | A | 13,000,000 | $0.00 | 18,861,719 | D | A |
| 02 Sep, 2019 | Steve N. Slilaty | Common Stock | A | 13,000,000 | $0.00 | 18,869,219 | D | A |
| 11 Sep, 2019 | Camille Sebaaly | Common Stock | A | 11,000,000 | $0.00 | 29,861,719 | D | A |
| 02 Sep, 2019 | Abderrazzak Merzouki | Common Stock | A | 13,000,000 | $0.00 | 18,850,000 | D | A |
| 27 Aug, 2018 | Steve N. Slilaty | Common Stock | A | 38,000,000 | $0.00 | 117,384,373 | D | A |
| 27 Aug, 2018 | Abderrazzak Merzouki | Common Stock | A | 38,000,000 | $0.00 | 118,467,000 | D | A |
| 27 Aug, 2018 | Camille Sebaaly | Common Stock | A | 38,000,000 | $0.00 | 117,234,373 | D | A |
| 20 Jun, 2018 | Abderrazzak Merzouki | Common Stock | A | 27,000,000 | $0.00 | 80,467,000 | D | A |
| 20 Jun, 2018 | Camille Sebaaly | Common Stock | A | 27,000,000 | $0.00 | 79,234,373 | D | A |
| 20 Jun, 2018 | Steve N. Slilaty | Common Stock | A | 27,000,000 | $0.00 | 79,384,373 | D | A |